Howe & Rusling’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-29
Closed -$4K 765
2022
Q3
$4K Hold
29
﹤0.01% 728
2022
Q2
$4K Sell
29
-3
-9% -$487 ﹤0.01% 709
2022
Q1
$6K Hold
32
﹤0.01% 615
2021
Q4
$6K Hold
32
﹤0.01% 628
2021
Q3
$6K Hold
32
﹤0.01% 598
2021
Q2
$6K Buy
32
+5
+19% +$904 ﹤0.01% 575
2021
Q1
$5K Buy
27
+4
+17% +$737 ﹤0.01% 628
2020
Q4
$4K Buy
+23
New +$3.79K ﹤0.01% 674

Other funds holding MSGS

Howe & Rusling's MSGS Position: Q4 2022 in Review

Howe & Rusling sold out of Madison Square Garden (MSGS) in Q4 2022, closing a stake of 29 shares — an estimated $4K sold.

Howe & Rusling first reported a position in MSGS in Q4 2020 and held it in 8 quarters. The position peaked at $6K in Q1 2022. 263 funds tracked by Wall St. Rank hold MSGS as of Q4 2022.

  • Howe & Rusling reported no remaining Madison Square Garden position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 29 Madison Square Garden shares in Q4 2022, an estimated $4K.
  • Howe & Rusling first reported a position in Madison Square Garden in Q4 2020 and held it in 8 quarters.
  • Howe & Rusling's Madison Square Garden position peaked at $6K in Q1 2022.
  • 263 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.